| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.2B | $7.6B | $8.1B | $2.3B | $10.6B | $9.4B | $9.7B | $8.6B |
| Cost of Revenue | $4.8B | $5.0B | $5.8B | $1.7B | $7.3B | $6.3B | $6.5B | $5.6B |
| Gross Profit | $2.4B | $2.5B | $2.4B | $2.8B | $3.3B | $3.1B | $3.2B | $3.0B |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B | $0.1B | $0.1B | $0.1B |
| SG&A Expense | $2.0B | $2.1B | $2.0B | $2.0B | $2.3B | $2.2B | $2.5B | $2.4B |
| Operating Income | $0.0B | $0.1B | $-0.1B | $-0.3B | $0.9B | $-0.6B | $-0.5B | $-7.8B |
| Net Income | $-0.3B | $-0.2B | $-0.4B | $-0.2B | $0.6B | $-0.8B | $0.1B | $-6.9B |
| EPS (Basic) | $-0.68 | $-0.52 | $-0.94 | $-0.60 | $1.34 | $-1.82 | $0.25 | $-14.60 |
| EPS (Diluted) | $-0.68 | $-0.52 | $-0.94 | $-0.60 | $1.34 | $-1.82 | $0.25 | $-14.60 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.7B | $11.0B | $12.2B | $13.3B | $14.2B | $14.7B | $15.6B | $17.7B |
| Current Assets | $2.7B | $2.8B | $3.4B | $4.1B | $4.3B | $4.6B | $4.1B | $7.7B |
| Cash & Equivalents | $0.2B | $0.2B | $0.3B | $0.3B | $0.4B | $1.0B | $0.3B | $0.5B |
| Total Liabilities | $8.3B | $8.3B | $9.1B | $9.7B | $10.1B | $10.8B | $10.6B | $12.4B |
| Current Liabilities | $2.5B | $2.4B | $2.9B | $3.1B | $3.3B | $3.6B | $3.0B | $3.3B |
| Stockholders' Equity | $2.4B | $2.8B | — | — | $4.1B | $3.9B | $5.0B | $5.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.5B | $0.9B | $-0.3B | $0.9B | $1.4B | $1.0B | $0.7B |
| Investing Cash Flow | $-0.2B | $-0.2B | $-0.2B | $0.3B | $-0.3B | $-0.2B | $0.7B | $4.8B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.1B | $-0.5B | $-0.7B | $-0.2B | $-1.1B | $-0.6B | $-1.9B | $-5.5B |